PhRMA names general counsel
Executive Summary
Conan Grames will join the Pharmaceutical Research & Manufacturers of America as VP and general counsel on Feb. 6. Grames is replacing Bruce Kuhlik, who left PhRMA in May for Merck (1"The Pink Sheet" May 2, 2005, In Brief). Diane Bieri, who has been serving as acting general counsel, is now chief deputy general counsel. Grames has been chairman of the International Law Practice Section of Kirton & McConkie in Salt Lake City, Utah, where he was responsible for developing the Health Services Group at the firm. Prior to joining Kirton & McConkie, Grames served as VP-international policy and compliance at Bristol-Myers Squibb, where he spent 17 years in various senior positions in the legal division of the company...
You may also be interested in...
PhRMA general counsel moving to Merck
Pharmaceutical Research & Manufacturers of America General Counsel Bruce Kuhlik will leave the association May 13 to join Merck as VP and associate general counsel on May 23. Kuhlik has been with PhRMA since October 2002. In addition to providing business and regulatory advice at Merck, he will work on defending the company against litigation related to the withdrawn COX-2 inhibitor Vioxx...
Podcast: The Week In European Consumer Health Industry News, 8 March 2021
HBW editors Tom Gallen and David Ridley discuss the big issues in the European consumer health market from the past week. In this edition, they delve into probiotics, digital health and Bayer’s recent turnaround.
The Ins And Outs Of The EU's Approach To COVID-19 Vaccine Procurement & Exports
EU trade expert Hervé Jouanjean considers the reasoning behind the EU’s vaccine procurement approach and Italy's decision to block exports of AstraZeneca's COVID-19 vaccine.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: